NO872810L - Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse. - Google Patents
Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse.Info
- Publication number
- NO872810L NO872810L NO872810A NO872810A NO872810L NO 872810 L NO872810 L NO 872810L NO 872810 A NO872810 A NO 872810A NO 872810 A NO872810 A NO 872810A NO 872810 L NO872810 L NO 872810L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- preparing
- procedure
- minoxidil
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 9
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 8
- 229960003632 minoxidil Drugs 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- USSBDBZGEDUBHE-UHFFFAOYSA-L magnesium;2-oxidooxycarbonylbenzoate Chemical compound [Mg+2].[O-]OC(=O)C1=CC=CC=C1C([O-])=O USSBDBZGEDUBHE-UHFFFAOYSA-L 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- FODOUIXGKGNSMR-UHFFFAOYSA-L magnesium;2-oxidooxycarbonylbenzoate;hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[O-]OC(=O)C1=CC=CC=C1C([O-])=O FODOUIXGKGNSMR-UHFFFAOYSA-L 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- IDCARVYLHZLEMC-UHFFFAOYSA-N (2,6-diaminopyrimidin-4-yl) 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC1=CC(N)=NC(N)=N1 IDCARVYLHZLEMC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- SWELIMKTDYHAOY-UHFFFAOYSA-N 2,4-diamino-6-hydroxypyrimidine Chemical compound NC1=CC(=O)N=C(N)N1 SWELIMKTDYHAOY-UHFFFAOYSA-N 0.000 description 1
- SXIUYERFFIKRTI-UHFFFAOYSA-N C1=CC(C)=CC=C1S(=O)(=O)OC1=CC(N)=[N+]([O-])C(N)=N1 Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC1=CC(N)=[N+]([O-])C(N)=N1 SXIUYERFFIKRTI-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003461 sulfonyl halides Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI864046A FI864046A7 (fi) | 1986-10-07 | 1986-10-07 | Menetelmä terapeuttisesti aktiivisen yhdisteen valmistamiseksi. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO872810D0 NO872810D0 (no) | 1987-07-06 |
| NO872810L true NO872810L (no) | 1988-04-08 |
Family
ID=8523270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO872810A NO872810L (no) | 1986-10-07 | 1987-07-06 | Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4866174A (de) |
| EP (1) | EP0270201B1 (de) |
| JP (1) | JPS6396175A (de) |
| KR (1) | KR880005095A (de) |
| AT (1) | ATE61584T1 (de) |
| AU (1) | AU590431B2 (de) |
| CA (1) | CA1268766A (de) |
| DE (1) | DE3768617D1 (de) |
| DK (1) | DK348687A (de) |
| ES (1) | ES2021048B3 (de) |
| FI (2) | FI864046A7 (de) |
| FR (1) | FR2604707B1 (de) |
| HU (1) | HUT44533A (de) |
| IL (1) | IL83351A0 (de) |
| NO (1) | NO872810L (de) |
| NZ (1) | NZ221011A (de) |
| PT (1) | PT85392B (de) |
| ZA (1) | ZA875174B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI871773A0 (fi) * | 1987-04-22 | 1987-04-22 | Farmos Oy | Foerfarande foer framstaellning av en terapeutiskt aktiv foerening. |
| FR2636840B1 (fr) * | 1988-09-23 | 1990-12-21 | Norchim Sarl | Sel du 6-piperidino-2,4-diaminopyrimidine-3-oxyde et de l'acide aceturique, leur preparation et leur application dermatocosmetologiques |
| WO1993006097A1 (en) * | 1991-09-20 | 1993-04-01 | Merck & Co., Inc. | Novel process for the preparation of anti-ulcer agents |
| FR2697251B1 (fr) * | 1992-10-22 | 1994-12-02 | Synthelabo | N-oxydes de dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl] pipéridin-1-yl]éthanol, leur procédé de préparation et leur application en thérapeutique. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3644364A (en) * | 1970-03-31 | 1972-02-22 | Upjohn Co | Compounds and process |
| US3998827A (en) * | 1971-04-07 | 1976-12-21 | The Upjohn Company | 6-amino-4-(substituted piperidino)-1,2-dihydro-1-hydroxy-2-iminopyrimidines |
| HU177601B (en) * | 1978-10-27 | 1981-11-28 | Egyt Gyogyszervegyeszeti Gyar | New process for preparing 6-piperidino-2,4-diamino-pyrimidine-3-oxide |
| DE3064301D1 (en) * | 1979-10-18 | 1983-08-25 | Interox Chemicals Ltd | Magnesium salts of peroxycarboxylic acids, processes for their preparation and their use as bleaching agents in washing compositions, and processes |
| US4483781A (en) * | 1983-09-02 | 1984-11-20 | The Procter & Gamble Company | Magnesium salts of peroxycarboxylic acids |
-
1986
- 1986-10-07 FI FI864046A patent/FI864046A7/fi not_active Application Discontinuation
-
1987
- 1987-06-16 FR FR8708342A patent/FR2604707B1/fr not_active Expired
- 1987-07-06 NO NO872810A patent/NO872810L/no unknown
- 1987-07-07 DK DK348687A patent/DK348687A/da unknown
- 1987-07-09 NZ NZ221011A patent/NZ221011A/xx unknown
- 1987-07-10 AU AU75517/87A patent/AU590431B2/en not_active Ceased
- 1987-07-13 US US07/072,725 patent/US4866174A/en not_active Expired - Fee Related
- 1987-07-15 ZA ZA875174A patent/ZA875174B/xx unknown
- 1987-07-16 EP EP87306305A patent/EP0270201B1/de not_active Expired - Lifetime
- 1987-07-16 DE DE8787306305T patent/DE3768617D1/de not_active Expired - Lifetime
- 1987-07-16 AT AT87306305T patent/ATE61584T1/de active
- 1987-07-16 ES ES87306305T patent/ES2021048B3/es not_active Expired - Lifetime
- 1987-07-23 PT PT85392A patent/PT85392B/pt unknown
- 1987-07-27 IL IL83351A patent/IL83351A0/xx unknown
- 1987-07-28 KR KR1019870008195A patent/KR880005095A/ko not_active Withdrawn
- 1987-08-19 HU HU873719A patent/HUT44533A/hu unknown
- 1987-09-01 CA CA000545907A patent/CA1268766A/en not_active Expired - Fee Related
- 1987-09-11 FI FI873933A patent/FI78910C/fi not_active IP Right Cessation
- 1987-10-06 JP JP62252299A patent/JPS6396175A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT85392B (en) | 1990-01-04 |
| ATE61584T1 (de) | 1991-03-15 |
| FR2604707A1 (fr) | 1988-04-08 |
| FI864046L (fi) | 1988-04-08 |
| CA1268766A (en) | 1990-05-08 |
| DK348687D0 (da) | 1987-07-07 |
| NZ221011A (en) | 1990-05-28 |
| KR880005095A (ko) | 1988-06-28 |
| FI864046A0 (fi) | 1986-10-07 |
| DE3768617D1 (de) | 1991-04-18 |
| ES2021048B3 (es) | 1991-10-16 |
| HUT44533A (en) | 1988-03-28 |
| EP0270201B1 (de) | 1991-03-13 |
| FI873933A0 (fi) | 1987-09-11 |
| FI78910C (fi) | 1989-10-10 |
| US4866174A (en) | 1989-09-12 |
| AU7551787A (en) | 1988-04-14 |
| DK348687A (da) | 1988-04-08 |
| PT85392A (en) | 1987-08-01 |
| NO872810D0 (no) | 1987-07-06 |
| AU590431B2 (en) | 1989-11-02 |
| ZA875174B (en) | 1988-01-20 |
| FI78910B (fi) | 1989-06-30 |
| FI864046A7 (fi) | 1988-04-08 |
| JPS6396175A (ja) | 1988-04-27 |
| FR2604707B1 (fr) | 1989-06-09 |
| IL83351A0 (en) | 1987-12-31 |
| EP0270201A1 (de) | 1988-06-08 |
| FI873933L (fi) | 1988-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1340960C (en) | Chroman derivatives | |
| EP0824524B1 (de) | Alpha-substituierte pyrimidin-thioalkylderivate und alkylether als inhibitoren viraler reverser transkriptfase | |
| CA2110944A1 (en) | Novel sulfonamides | |
| NO300874B1 (no) | Anvendelse av sulfonamider som virkestoffer ved fremstilling av legemidler for behandling av kretslöpssykdommer | |
| IL102138A (en) | Sulphonamides their preparation and intermediates therefor and pharmaceutical compositions containing the sulphonamides | |
| SU786894A3 (ru) | Способ получени производных 3,4-дигидрохиназолина или их солей | |
| WO2010077062A2 (en) | Preparation method of statin compound and benzothiazolyl sulfone compound used therein | |
| NO872810L (no) | Fremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse. | |
| HUT56096A (en) | Process for producing chromane derivatives and pharmaceutical compositions containing them | |
| CN104994855B (zh) | 制备逆转录酶抑制剂的方法 | |
| KR100654265B1 (ko) | 4-(헤테로아릴-메틸)-할로겐-1(2ｈ)-프탈라지논의 제조 방법 | |
| JP3156026B2 (ja) | ホスホン酸ジエステル誘導体 | |
| HU196207B (en) | Process for preparing 9-/2-hydroxy-ethoxy/-methyl-guanine | |
| HU219231B (en) | N-5-protected 2,5-diamino-4,6-dichloro-pyrimidine derivatives , process for producing them and intermediates | |
| NO147838B (no) | Mellomprodukt til bruk ved fremstilling av det hypotensive middel 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimetoksykinazolin | |
| US3180866A (en) | Substituted sulfapyrimidine derivatives | |
| US3431263A (en) | Certain 2-benzenesulfonamido-5-oxypyrimidines | |
| RU2837452C1 (ru) | Способ синтеза противоопухолевого соединения и его промежуточных соединений | |
| SU1117298A1 (ru) | Способ получени производного урацила | |
| JP3013778B2 (ja) | ベンゼンスルホンアミド誘導体及びその製法 | |
| HU198949B (en) | Process for producing 5-substituted-3'azido-2',3'-dideoxyribonucleosides | |
| JPS6031832B2 (ja) | １−（２′−テトラヒドロフリル）−５−フルオロウラシルの製造法 | |
| JPS609036B2 (ja) | ウラシル誘導体の製法 | |
| NO770855L (no) | Fremgangsm}te for fremstilling av 5-fluoruracilderivater | |
| HU177579B (hu) | Eljárás 3-|(2-metil-4-amino-5-pirimidinil)-iiietil|“5-(2-hídroxietilH-metiI- -2(3H)-tiazoltion előállítására |